GlassScriptPhysician profile
Sandesh Rao
NPI 1265708093
$21,176.61
in general payments reported to CMS, 2019-2025
13 companies · $4,673 in 2025
The $4,673 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,200 · 2022: $6,477 · 2023: $2,789 · 2024: $1,037 · 2025: $4,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,277 · Food and Beverage: $3,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,276.76 |
| Food and Beverage | $3,222.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16,220.27 | 2021-2025 | Journey II, Real Intelligence, Legion Revision |
| Zimmer Biomet Holdings, INC. | $1,855.89 | 2022-2025 | Avenir, Persona, Rosa |
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2021 | |
| Orthalign INC | $612.20 | 2022 | |
| Stryker Corporation | $515.63 | 2022-2023 | Aequalis Ascend Flex, Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Medtronic, INC. | $263.34 | 2022 | |
| Davol INC. | $159.40 | 2024 | |
| Microport Orthopedics INC | $125.45 | 2022 | |
| Lima USA, INC. | $92.31 | 2022 | |
| Medacta USA, INC. | $59.00 | 2024 | |
| Medical Device Business Services, INC. | $29.16 | 2023 | Attune |
| Depuy Synthes Sales INC. | $29.10 | 2024 | |
| Ethicon US, LLC | $14.86 | 2025 | Dermabond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandesh Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.